New MRI technique could sharpen brain tumor biopsies
NCT ID NCT03458676
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 26 times
Summary
This study at MD Anderson Cancer Center is testing whether an advanced MRI scan can help doctors more accurately target brain tumor biopsies. About 62 adults with suspected brain tumors will get an advanced MRI before their standard surgery. Researchers will compare the imaging results with tissue samples to see if the new method improves biopsy accuracy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could improve how doctors target brain tumor biopsies, leading to more accurate diagnoses and better treatment planning.
What could go wrong
This is an early-stage study with only 62 participants, focused on comparing imaging methods rather than direct patient outcomes. The advanced MRI is not yet FDA-approved and may not prove superior in practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.